156 related articles for article (PubMed ID: 36853141)
1. Clinical utility of target-based next-generation sequencing for drug-resistant TB.
Mansoor H; Hirani N; Chavan V; Das M; Sharma J; Bharati M; Oswal V; Iyer A; Morales M; Joshi A; Ferlazzo G; Isaakidis P; Ndlovu Z; England K
Int J Tuberc Lung Dis; 2023 Jan; 27(1):41-48. PubMed ID: 36853141
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
[TBL] [Abstract][Full Text] [Related]
3. Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs.
Wu SH; Xiao YX; Hsiao HC; Jou R
Microbiol Spectr; 2022 Dec; 10(6):e0260522. PubMed ID: 36255328
[TBL] [Abstract][Full Text] [Related]
4. The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
Shibabaw A; Gelaw B; Gebreyes W; Robinson R; Wang SH; Tessema B
PLoS One; 2020; 15(2):e0229040. PubMed ID: 32053661
[TBL] [Abstract][Full Text] [Related]
5. Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.
Singh K; Kumari R; Gupta S; Tripathi R; Srivastava A; Shakya V; Gupta A; Anupurba S
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):56. PubMed ID: 34446022
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by a novel GenoType® MTBDRsl assay.
Singh AK; Maurya AK; Kant S; Umrao J; Kushwaha RA; Nag VL; Dhole TN
J Postgrad Med; 2013; 59(3):179-85. PubMed ID: 24029194
[TBL] [Abstract][Full Text] [Related]
7. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
8. Operationalising targeted next-generation sequencing for routine diagnosis of drug-resistant TB.
Iyer A; Ndlovu Z; Sharma J; Mansoor H; Bharati M; Kolan S; Morales M; Das M; Issakidis P; Ferlazzo G; Hirani N; Joshi A; Tipre P; Sutar N; England K
Public Health Action; 2023 Jun; 13(2):43-49. PubMed ID: 37359066
[TBL] [Abstract][Full Text] [Related]
9. Targeted sequencing from cerebrospinal fluid for rapid identification of drug-resistant tuberculous meningitis.
Tram TTB; Trieu LPT; Nhat LTH; Thu DDA; Quang NL; Bang ND; Chau TTH; Thwaites GE; Walker TM; Ha VTN; Thuong NTT
J Clin Microbiol; 2024 Apr; 62(4):e0128723. PubMed ID: 38466092
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the QuantaMatrix Multiplexed Assay Platform for Molecular Diagnosis of Multidrug- and Extensively Drug-Resistant Tuberculosis Using Clinical Strains Isolated in Myanmar.
Chang Y; Kim S; Kim Y; Ei PW; Hwang D; Lee J; Chang CL; Lee H
Ann Lab Med; 2020 Mar; 40(2):142-147. PubMed ID: 31650730
[TBL] [Abstract][Full Text] [Related]
11. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
[TBL] [Abstract][Full Text] [Related]
12. First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
Kabahita JM; Kabugo J; Kakooza F; Adam I; Guido O; Byabajungu H; Namutebi J; Namaganda MM; Lutaaya P; Otim J; Kakembo FE; Kanyerezi S; Nabisubi P; Sserwadda I; Kasule GW; Nakato H; Musisi K; Oola D; Joloba ML; Mboowa G
Antimicrob Resist Infect Control; 2022 May; 11(1):68. PubMed ID: 35550202
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the MolecuTech
Cho EJ; Kang MR; Kim JH; Lee JI; Son ES; Park CH; Aung WW; Lee JS
Int J Tuberc Lung Dis; 2022 Sep; 26(9):869-874. PubMed ID: 35996285
[No Abstract] [Full Text] [Related]
14. Performance of the MTBDRsl assay in Georgia.
Tukvadze N; Bablishvili N; Apsindzelashvili R; Blumberg HM; Kempker RR
Int J Tuberc Lung Dis; 2014 Feb; 18(2):233-9. PubMed ID: 24429319
[TBL] [Abstract][Full Text] [Related]
15. Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples.
Cabibbe AM; Spitaleri A; Battaglia S; Colman RE; Suresh A; Uplekar S; Rodwell TC; Cirillo DM
J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32727827
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Genotype MTBDR
Javed H; Bakuła Z; Pleń M; Hashmi HJ; Tahir Z; Jamil N; Jagielski T
Front Microbiol; 2018; 9():2265. PubMed ID: 30319577
[TBL] [Abstract][Full Text] [Related]
17. Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia.
Claassens M; Dreyer V; Nepolo E; Mokomele Q; van Rooyen G; Ruswa N; Günther G; Niemann S
Microbiol Spectr; 2022 Oct; 10(5):e0158622. PubMed ID: 36165641
[TBL] [Abstract][Full Text] [Related]
18. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
[TBL] [Abstract][Full Text] [Related]
19. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
Vashistha H; Hanif M; Saini S; Khanna A; Sharma S; Sidiq Z; Ahmed V; Dubey M; Chopra KK; Shrivastava D
Indian J Tuberc; 2016 Jul; 63(3):144-148. PubMed ID: 27865234
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
